📰 Session Time News
Session Time News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Session Time. Real-time updates on events, politics, business and more.
May 22, 2024
VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the...
May 6, 2024
NEW YORK, May 6, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...
October 20, 2023
SANTA ANA - NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell...
October 19, 2023
SANTA ANA, Calif., Oct. 19, 2023 -- NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK...
September 6, 2023
LOS ANGELES, Sept. 06, 2023 -- Super League , a global leader in providing immersive experiences across the worlds largest metaverse gaming platforms, and the internationally-renowned...
September 3, 2023
Watch F1 via live stream or on TV: dates and times for the 2023 Italian Grand Prix from Monza, including qualifying and the grand prix.
July 11, 2023
/PRNewswire/ -- Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings on its...
November 30, 2022
Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma support continued dose escalation to...
November 3, 2022
Multiple presentations will highlight the clinical utility of ZYNLONTA (loncastuximab tesirine-lpyl) in DLBCL and Cami (camidanlumab tesirine) in Hodgkin lymphoma ADC Therapeutics SA (NYSE: ADCT)
May 26, 2022
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress (June